Natural Gas Services Group: Pillar Biosciences Launches oncoReveal® Lymphoid for Advanced Tumor Profiling
- Pillar Biosciences launched oncoReveal® Lymphoid, enhancing diagnostic capabilities for lymphoid malignancies with next-generation sequencing.
- The kit offers precise genetic profiling and integrates automated software for improved mutation identification and diagnostic accuracy.
- Pillar's advancements support personalized medicine, addressing the rising demand for effective cancer diagnostics and treatment decisions.
### Advancements in Tumor Profiling: Pillar Biosciences Launches oncoReveal® Lymphoid
Pillar Biosciences, Inc. recently introduces its next-generation sequencing (NGS) kit, oncoReveal® Lymphoid, a significant advancement in tumor profiling specifically designed for lymphoid malignancies. This research-use-only (RUO) kit is aimed at local laboratories looking to enhance their diagnostic capabilities with efficient NGS-based testing solutions for conditions such as lymphomas. The oncoReveal Lymphoid panel examines 84 genes, including the complete coding DNA sequence of 29 critical genes, enabling comprehensive insights into the genetic underpinnings of lymphoid cancers. The streamlined, single-tube NGS workflow is tailored for any laboratory equipped with NGS technology, making it a practical option for molecular pathology labs striving to provide accurate diagnostics.
The innovative technology behind the oncoReveal Lymphoid leverages Pillar’s proprietary Stem-Loop Inhibition-Mediated amplification (SLIMamp®), which facilitates precise genetic profiling down to a variant allele frequency (VAF) of just 2%. This high level of sensitivity is vital for detecting somatic mutations in low-frequency variants, which are often pivotal in guiding targeted therapies. Moreover, the panel is integrated with PiVAT®, an automated bioinformatics software that enhances the identification of mutations, ensuring both high sensitivity and specificity in results. This combination of advanced technology and robust software support positions Pillar Biosciences at the forefront of molecular diagnostics, ultimately aiming to improve outcomes for patients diagnosed with lymphoid malignancies.
In the context of rising cancer incidences, Pillar’s initiative comes at a crucial time. In the U.S. alone, someone is diagnosed with leukemia, lymphoma, or myeloma every three minutes, with an estimated 187,740 cases anticipated in 2024. This represents 9.4% of the expected total of 2,001,140 new cancer cases. With the global incidence of lymphoid malignancies exceeding 1.6 million cases in 2021, the introduction of the oncoReveal Lymphoid represents a significant step towards enhancing precision therapy selection and increasing accessibility to complex NGS testing. As the demand for efficient and accurate diagnostic tools grows, Pillar Biosciences is poised to make a meaningful impact in the field of cancer diagnostics.
Related Cashu News

Kosmos Energy Gains Inclusion in Russell Indices Amidst Stock Volatility and Growth Potential
Kosmos Energy (Ticker: KOS) is experiencing a significant shift in its market presence as it gains inclusion in key Russell growth benchmark indices, notably the Russell 2000 Growth and Russell 3000 G…

Chevron Navigates Rising Gas Prices and Tax Increases Amid California's Energy Policy Debate
Chevron (Ticker: CVX) faces a complex landscape in California as high fuel prices continue to burden residents. Recent developments signal the impending gas tax increase slated to raise California's e…

ConocoPhillips Enhances Capital Flexibility Amidst Rising Fuel Prices and Market Volatility
ConocoPhillips (Ticker: COP) actively positions itself in the evolving energy sector by filing a new Shelf Registration, a strategic maneuver that enhances its ability to raise capital flexibly. This…

SLB Launches Digital Marketplace to Enhance Innovation and Market Position in Energy Sector
SLB (Ticker: SLB) announces the launch of the SLB Digital Marketplace, a significant development that bolsters its technological presence within the energy sector. This new platform features roughly 2…

